FDA今年十月刚批准的疗法(CAR T-cell therapy),但是有条件限制。烦请各位好人帮忙看一下。

来源: 2017-11-16 09:14:00 [博客] [旧帖] [给我悄悄话] 本文已被阅读:

这样,我好对照朋友情况看看她是否适合接受这种治疗。

 

Conditions treated

The FDA-approved indications for CAR T-cell therapy, Yescarta made by Kite Pharma Gilead, is aggressive B-cell non-Hodgkin's lymphoma, including the diagnosis of:

  • Diffuse large B-cell lymphoma
  • Primary mediastinal B-cell lymphoma
  • Large B-cell lymphoma transformed from follicular lymphoma
  • Aggressive B-cell lymphoma not otherwise specified (NOS)

Patients who have relapsed or refractory disease after two or more types of prior treatments could be evaluated for CAR T-cell therapy with Yescarta.

In addition, Mayo Clinic has multiple active clinical trials testing CAR T-cell therapy in lymphoma and other cancer types.

 

请问:

“including the diagnosis of:

  • Diffuse large B-cell lymphoma
  • Primary mediastinal B-cell lymphoma
  • Large B-cell lymphoma transformed from follicular lymphoma
  • Aggressive B-cell lymphoma not otherwise specified (NOS)”

这段话是什么意思啊?是这种疗法要做的事?这种疗法需要的前提?还是这种疗法需要确诊上述问题?

拜谢!